Clinical OMICS

SEP-OCT 2017

Healthcare magazine for research scientists, labs, pathologists, hospitals, cancer centers, physicians and biopharma companies providing news articles, expert interviews and videos about molecular diagnostics in precision medicine

Issue link: https://clinicalomics.epubxp.com/i/879908

Contents of this Issue

Navigation

Page 4 of 47

www.clinicalomics.com September/October 2017 Clinical OMICs 3 (continued on next page) News Retail Engagement Interpreta and higi Eye Healthcare 'Roadmaps' Using Patient Data Collected at Grocers, Pharmacies By Alex Philippidis B iometric data from higi will be integrated with clinical, claims, and genomic data from Interpreta under a partnership designed to enable physicians and insurers to cre- ate personalized-care "roadmaps" for patients. The partnership will rely on data collected by higi at its nearly 11,000 FDA-cleared, self-screening health stations—the largest such network in North America, the company says. The stations are designed to capture biometric data from shoppers at loca- tions within food, chain drug, mass merchant, and club retailers. According to higi, 78% of the U.S. population lives within 5 miles of one of its health stations, which have been used by more than 43 million consumers. Data collected from those sta- tions includes blood pressure, pulse, BMI, weight, body composition, and self-screening questions. Through the collaboration, that data can be accessed by users through higi's mobile and web app, then interpreted and integrated with clinical, claims and genomic data in real time by Interpreta, a San Diego-based health- care analytics company. "Interpreta and higi hope to trans- form the way healthcare is delivered," Interpreta CEO and cofounder Ahmed Ghouri, M.D., said. "In addition to bio- metric data, there is a strong thesis that continuous engagement with patients, outside of the 15-minute annual office visit, will provide a way for patients to stay aware of their health and for providers to stay in touch with them." Ghouri and Khan Siddiqui, M.D., higi's CTO and CMO, said their com- panies aim to close gaps in healthcare by promoting greater engagement and sharing of data by physicians and their patients. Interpreta and higi seek to help physicians and insurers create per- sonalized-care "roadmaps" designed to inform decisions on patient care as well as increase physician engage- ment with those patients. The compa- nies say the data is completely private, and exchanged only if patients choose to share it. "Health plans and large provider groups currently use Interpreta to prioritize members, calculate gaps in care, predict and suggest opportuni- ties for risk adjustment, and under- stand pharmacy-related opportunities for intervention. The addition of higi data for specific members and patients can further enrich and inform the analytics that Interpreta performs," Siddiqui said. "In turn, higi provides the means to engage the consumer in retail to act on their personalized care roadmap, informing care decisions and more effectively closing gaps in care." Interpreta synchronizes clinical and genomics data from a variety of sources, including health plans, pro- More than 5.5 million people have signed up for a higi account offering an all-in-one biometric and activity data feed for personal health management and information sharing with friends, family, and providers.

Articles in this issue

Archives of this issue

view archives of Clinical OMICS - SEP-OCT 2017